Gujarat Themis Biosyn Limited announced key outcomes from its Board Meeting held on February 5, 2026. The Board approved the unaudited financial results for the quarter and nine months ended December 31, 2025. Furthermore, the Board approved the re-appointment of Ms. Kirandeep Madan as Non-Executive Woman Independent Director for a second term of five years, from May 1, 2026, to April 30, 2031, subject to shareholder approval. In a significant finance function enhancement, Mr. Krupesh Patel has been appointed as the new Chief Financial Officer (CFO) and Key Managerial Personnel (KMP), effective April 1, 2026. This follows the transition of the current CFO, Mr. Bhavik Shah, to a different role within the organization, focusing on plant-related accounting activities. Mr. Patel brings 15 years of experience across various sectors and holds an MBA (Finance), is a Cost and Management Accountant (ICWA), Company Secretary (CS), and holds a Law degree (LLB).
